000			02167nam a2200361 i 4500
001			2133319
003			StDuBDS
005			20231010110659.0
006			m|||||o||d||||||||
007			cr |||||||||||
008			230117s2018 enka fob 001|0|eng|d
020			_a9781910797600 (PDF ebook) : _cNo price
020			_z9781910797594 (pbk.) : _cNo price
020			_z9781910797600
040			_aStDuBDS _beng _cStDuBDS _erda _epn
060		4	_aWH 250
100	1		_aBlum, William, _eauthor.
245	1	0	_aAcute myeloid leukemia / _h[e-book]
250			_aFirst edition.
264		1	_aAbingdon, Oxford : _bHealth Press, _c2018.
300			_a1 online resource (87 pages) : _billustrations (colour).
490	1		_aFast facts
500			_aAlso issued in print: 2018.
504			_aIncludes bibliographical references and index.
520	8		_aThis last year has seen the approval of the first targeted treatments for acute myeloid leukemia (AML) - following decades with no new developments and a poor prognosis for most patients with the disease. The new drugs reflect the remarkable progress that has been made in our understanding of the pathophysiology of AML and its underlying cytogenetic and molecular abnormalities - which differ not only between patients but also within a patient over time and with treatment. This books provides a comprehensive yet concise foundation for understanding AML - from basic epidemiology, diagnosis, classification and the current 'standard' treatment, through to recent advances in our understanding of the cytogenetic and molecular underpinnings of the disease, such as the IDH2 mutation, and the future for tailored therapy.
521			_aSpecialized.
588			_aDescription based on online resource; title from PDF title page (viewed on January 17, 2023).
650		0	_aAcute myeloid leukemia.
650		2	_aLeukemia, Myeloid, Acute.
700	1		_aMathews, Vikram, _eauthor.
830		0	_aFast facts.
856	4	0	_uhttps://app.kortext.com/Shibboleth.sso/Login?entityID=https://idp.eng.nhs.uk/openathens&target=https://app.kortext.com/borrow/2133319 _yEligible NHS OpenAthens account holders click here for access
999			_c96860 _d96860